Table 48Studies included in the review of antipsychotic medication for people whose illness has not responded adequately to treatment

Treatmentvs. comparator
CHLCLZFLUPHENHALOLZPERQUERISZIPZOT
ARIKANE2007B [6wks, N=300]
CLZClaghorn 1987 [4–8wks, N=151]
Hong 1997 [12wks, N=40]
Kane 1988 [6wks, N=268]
Buchanan 1998 [10wks, N=75]
Klieser 1989 [6wks, N=32]
Rosenheck 1997 [52wks, N=423]
VOLAVKA2002 [14wks, N=77]
Beuzen 1998 [18wks, N=180]
Bitter 1999 [18wks, N=150]
Oliemeulen 2000 [8wks, N=36]
VOLAVKA2002 [14wks, N=79]
MELTZER2008 [26wks, N=40]
Anand 1998 [12wks, N=273]
Bondolfi 1998 [8wks, N=86]
Breier 1999 [6wks, N=29]
Chowdhury 1999 [16wks, N=60]
VOLAVKA2002 [14wks, N=81]
Meyer-Lindberg 1996 [6wks, N=50]
OLZConley 1998a [8wks, N=84]Beuzen 1998 [18wks, N=180]
Bitter 1999 [18wks, N=150]
Oliemeulen 2000 [8wks, N=36]
VOLAVKA2002 [14wks, N=79]
MELTZER2008 [26wks, N=40]
Altamura 1999 [14wks, N=28]
Breier 2000 [6wks, N=526]
BUCHANAN2005 [16wks, N=63]
VOLAVKA2002 [14wks, N=80]KINON2006A [24wks, N=394]
QUECONLEY2005 [12wks, N=25]Emsley 1999 [8wks, N=288]CONLEY2005 [12wks, N=25]
RISAnand 1998 [12wks, N=273]
Bondolfi 1998 [8wks, N=86]
Breier 1999 [6wks, N=29]
Chowdhury 1999 [16wks, N=60]
VOLAVKA2002 [14wks, N=81]
CONLEY2005 [12wks, N=26]Heck 2000 [6wks, N=77]
Kern 1998/1999 [8wks, N=64]
SEE1999 [5wks, N=20]
VOLAVKA2002 [14wks, N=80]CONLEY2005 [12wks, N=25]
ZIPKINON2006A [24wks, N=394]
ZOTMeyer-Lindberg 1996 [6wks, N=50]

From: 10, Clinical evidence summary tables

Cover of Schizophrenia
Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update) [Internet].
NICE Clinical Guidelines, No. 82.
National Collaborating Centre for Mental Health (UK).
Leicester (UK): British Psychological Society; 2009 Mar.
Copyright © 2009, National Collaborating Centre for Mental Health.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.